{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-015389","form_type":"8-K","ticker":"MGRX","cik":"0001938046","company_name":"MANGOCEUTICALS, INC.","filed_at":"2023-05-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:41.605770+00:00","generated_at":"2026-06-15T23:09:27.005700+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Mangoceuticals appoints Amanda Hammer as COO; CEO salary raised to $300k","bullets":["Amanda Hammer appointed COO effective May 1, 2023; replaces Jonathan Arango who remains President/Secretary/Board member.","COO receives $150k annual salary, 75k vested common shares, and options for 150k shares at $1.10 strike.","CEO Jacob Cohen's salary increased from $180k to $300k per year, effective May 1, 2023.","Hammer previously served as director of e-Commerce since Oct 2022; prior COO at D Magazine Partners."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-015389","json":"https://secwatch.observer/filing/0001493152-23-015389.json","markdown":"https://secwatch.observer/filing/0001493152-23-015389.md","text":"https://secwatch.observer/filing/0001493152-23-015389.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1938046/000149315223015389/0001493152-23-015389-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1938046/000149315223015389/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-15T23:09:27.005700+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"2c92b987aa","claim":"Amanda Hammer was appointed as Chief Operating Officer at MANGOCEUTICALS, INC..","evidence_excerpt":"Effective on May 1, 2023, the Board of Directors of Mangoceuticals, Inc. (the “ Company ”, “ we ” and “ us ”) appointed Mrs. Amanda Hammer, as the Chief Operating Officer (COO) of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1938046/000149315223015389/0001493152-23-015389-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Operating Officer"}],"fact_type":"executive_change"},{"claim_id":"44872780a5","claim":"Jonathan Arango changed role as Chief Operating Officer at MANGOCEUTICALS, INC..","evidence_excerpt":"As a result of such appointment Jonathan Arango, the President, Secretary and member of the Board of Directors of the Company, ceased serving as COO, but will continue serving in his other roles with the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1938046/000149315223015389/0001493152-23-015389-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"ceased serving as"},{"label":"Role","value":"Chief Operating Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}